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Endothelial cell protection against ischemia/reperfusion injury The return of blood flow to ischemic tissue can result
by lecithinized superoxide dismutase. in recovery of normal cellular function, but paradoxically,
Background. Organs used for transplantation may experi- the tissue may become injured during the process of re-ence long periods of cold ischemic preservation and conse-
perfusion. In organ transplantation, prolonged ischemicquently oxygen free radical-mediated damage following reper-
periods are experienced during cold preservation. Hence,fusion. Lecithinized superoxide dismutase (lec-SOD) is a novel
free radical scavenger that has been shown to bind with high when blood is returned to the ischemic organ following
affinity to cell membranes. The aim of this study was to deter- anastomosis, the organ undergoes some level of reperfu-
mine whether lec-SOD bound to endothelial cells under organ sion injury. Ischemia/reperfusion injury (IRI) is a nonspe-preservation conditions to mediate direct antioxidant activity
cific inflammatory process that is initiated at the endothelialat the endothelial cell surface and thus offer protection against
surface of the vasculature and may have an additionalthe harmful effects of ischemia/reperfusion injury.
Methods. An in vitro study was performed on large vessel impact on post-transplantation events by increasing sus-
endothelial cells (HUVEC) and a human microvascular endo- ceptibility to subsequent acute rejection episodes and the
thelial cell line HMEC-1, to investigate the potential therapeu-
vascular changes associated with chronic rejection [1–3].tic benefits of incorporating lec-SOD into organ preservation
A key feature of IRI is the generation of reactive oxygensolution. A cold hypoxia/reoxygenation system was developed
to examine lec-SOD binding affinity to endothelial cells, pro- species resulting from the return of oxygen to ischemic
tection against hypoxia/reoxygenation-induced cell death, and tissue. In vitro evidence has demonstrated that the pro-
neutrophil adhesion. duction of superoxide (·O2) on the surface of endothelialResults. Lec-SOD bound to endothelial cells with higher af-
cells results from the action of xanthine oxidase, an en-finity than unmodified recombinant human superoxide dismu-
zyme that accumulates in ischemic tissue as a conse-tase (rhSOD) and significantly protected both HUVEC and
HMEC-1 from cell death following 27 hours of cold hypoxia quence of the proteolytic cleavage of xanthine dehydro-
(P  0.01). Furthermore, neutrophil adhesion to the endothe- genase [4, 5]. Superoxide forms the precursor for other
lium stimulated by hypoxia and reoxygenation was significantly highly reactive free radicals such as hydrogen peroxideinhibited by treatment with lec-SOD but not by lecithin or
(H2O2) and the hydroxyl radical (OH), which togetherrhSOD (P  0.01). Analysis by flow cytometry demonstrated
may form a potent cytotoxic cocktail capable of inactivat-that E-selectin and ICAM-1 were up-regulated by hypoxia/
reoxygenation that was inhibited in part by lec-SOD. ing cellular enzymes and initiating inflammatory path-
Conclusions. The results from this study suggest that incor- ways. The endothelial lining of the organ vasculature plays
poration of lec-SOD into organ preservation solutions provides a critical role in the inflammatory response arising fromeffective protection to endothelial cells against cold ischemia
IRI. In vitro studies have shown that endothelial cellsand reperfusion injury following transplantation.
exposed to hypoxia/reoxygenation (to simulate the physio-
logical events of IRI) produce oxygen free radicals re-
sulting in up-regulated expression of leukocyte adhesion
molecules, E-selectin, and intercellular adhesion mole-Key words: transplantation, cold organ storage, free radical damage,
organ preservation, antioxidants, anastomosis. cule-1 (ICAM-1), thus enabling neutrophil adherence
[6–10]. Similarly, these events are observed in vivo whereReceived for publication December 18, 2000
oxygen-free radical production, induced adhesion mole-and in revised form February 19, 2001
Accepted for publication March 12, 2001 cule expression, and neutrophil infiltration have been ob-
served in animal models of organ IRI [11–13]. Further- 2001 by the International Society of Nephrology
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more, it is evident from these models of IRI and in a cold hypoxia/reoxygenation model to investigate the
effect of lec-SOD on hypoxia/reoxygenation-induced cellclinical renal transplantation that IRI becomes manifest
death, neutrophil adhesion, and adhesion molecule ex-in the microvasculature where the inflammatory changes
pression in endothelial cells.are most pronounced.
The burst of free radical production at reperfusion
overwhelms the cellular capacity for protection against METHODS
free radical-mediated damage as natural sources of anti-
Isolation of HUVECoxidants (for example, glutathione, ascorbic acid, trypto-
Umbilical cords were obtained from the Delivery Suite,phane, superoxide dismutase) become depleted during
Department of Obstetrics and Gynaecology (John Rad-the period of ischemic storage. In transplantation, allevia-
cliffe Hospital, Oxford, UK), and isolation of human um-tion of the effects of IRI have been attempted with the
bilical vein endothelial cells (HUVEC) was performeddevelopment of complex organ preservation solutions
according to the method of Jaffe et al [24]. HUVECsuch as Euro-Collins, HTK (histidine, tryptophan, -keto-
were cultured in M199 medium (Sigma, Poole, Dorset,glutarate), UW (University of Wisconsin), and Marshall’s
UK) supplemented with 20% heat-inactivated fetal calf(hypertonic citrate) solution that contain a variety of
serum (PAA Labs, UK), 2 mmol/L L-glutamine (PAAbuffers, slowly permeable solutes to prevent edema, glu-
Labs, Yeovil, UK), 1  endothelial cell growth factorcose metabolites, and free radical scavengers [14]. Never-
(Sigma), 100 U/mL penicillin, and 100 g/mL streptomy-theless, the addition of free radical scavengers to preser-
cin (PAA Labs) and incubated at 37C in an humidifiedvation solutions (for example, allopurinol, glutathione,
incubator in 95% air and 5% CO2. Cells were passaged byascorbate) has been used with limited success (because
incubation with phosphate-buffered saline (PBS)/1 mmol/Lof their short half-lives) and they have not been routinely
ethylenediaminetetraacetic acid (EDTA) at 4C for 10incorporated into transplantation regimens [15].
minutes, followed by a ten-minute incubation at 37C,Other antioxidant strategies have involved the infu-
and were never used beyond passage 4 in any experi-sion of superoxide dismutase intravenously to recipients
ment. Confirmation of endothelial characteristics wasof renal allografts at reperfusion. Early experimental stud-
determined by the cobblestone morphology of confluenties demonstrated that superoxide dismutase (SOD) im-
monolayers and by FACS analysis for constitutive surfaceproved early graft function [16, 17], while in clinical renal
expression of CD31 and cytokine-inducible E-selectin ex-transplantation, administration of SOD at the time of re-
pression [following incubation with 200 U/mL TNF (Cam-perfusion did not appear to benefit renal function in the first
bridge Biosciences Ltd., Cambridge, UK) for 6 hours].
week [18], but significantly improved long-term allograft
survival [19]. The effectiveness of free radical scavengers Culturing the human microvascular endothelial cell
could be improved if the agents had a longer pharmaco- line, HMEC-1
logical half-life and if the protection was localized to the A human microvascular endothelial cell line, HMEC-1,
endothelial surface where the initial burst of superoxide was obtained from the Centre for Disease Control (Em-
production is generated following IRI. Indeed, develop- ory University, Atlanta, GA, USA) [25]. The cells were
ment of such a drug may prove to be of significant thera- maintained in culture in MCDB-131 medium (Sigma)
peutic benefit not only in organ transplantation, but also supplemented with 15% heat-inactivated fetal calf serum
in other vascular disorders where oxygen free radical- (PAA Labs), 10 ng/mL epidermal growth factor (Sigma),
induced damage is of pathological importance. 1 g/mL hydrocortisone (Sigma), 100 U/mL penicillin,
The aim of this study was to investigate the potential and 100 g/mL streptomycin (PAA Labs). Cells were
efficacy of a novel agent, lecithinized-recombinant hu- passaged at 80% confluence (days 4 and 5) using the
man CuZn-superoxide dismutase (lec-SOD), which has method described for HUVEC.
been shown to have a high affinity for cell membranes,
Source of lec-SOD, rhSOD and lecithinto have a longer half-life, and to be a more effective free-
radical scavenger than unmodified, recombinant human Lecithinized superoxide dismutase (PSD04), rhSOD,
CuZn-SOD (rhSOD) [20]. The increased affinity of lec- and lecithin were kindly provided by the Seikagaku Cor-
SOD for cell membranes is attributable to the covalent poration (Tokyo, Japan). The pharmacological activity
linkage of four molecules of lecithin (a highly cytotropic of lec-SOD and rhSOD per 100 g protein was reported
phospholipid molecule found ubiquitously in cellular as 300 U and 510 U, respectively (as determined by the
membranes [21, 22]) to one molecule of rh-SOD [23]. xanthine/xanthine oxidase system) [26].
In renal transplantation, it would be desirable to incorpo-
Chemiluminescent analysis of rhSODrate lec-SOD into the preservation solution during cold
and lec-SOD activitystorage and thereby localize its protective capacity to the
endothelium. To simulate the physiological conditions The pharmacological activity of rhSOD and lec-SOD
following incorporation into Marshall’s organ preserva-experienced in the clinical setting, we have developed
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tion solution was determined using a xanthine/xanthine
oxidase system based on a method by Skatchkov et al
[27]. Two milliliters of Kreb’s HEPES buffer was pre-
heated to 37C and added to a cuvette with 1.0 mol/L
Cypridina luciferin analog (CLA) together with 200 L
of the test sample. Background luminescence levels were
measured over a two-minute period in the luminometer
(Turner Design TD20-20, Steptech, Stevenage, UK). The
generation of superoxide was chemically induced by the
addition of 10 L xanthine oxidase (0.002 U; Sigma) and
80 L xanthine (400 nmol/L; Sigma), and the level of
luminescence produced from superoxide reactivity with
CLA was recorded for five minutes. The data were ana-
lyzed using AcqKnowledge software.
Binding of lec-SOD to endothelial cells
Flow cytometry. Endothelial cells were incubated with
lec-SOD and rhSOD incorporated into Marshall’s pres-
Fig. 1. Effect of recombinant human CuZn superoxide dismutaseervation solution (Baxter Healthcare Ltd., Newbury,
(rhSOD) and lecithinized superoxide dismutase (lec-SOD) on Cyprid-UK) for 3 and 24 hours at 4C. Following extensive ina luciferin analog (CLA) chemiluminescence profiles induced by xan-
washing with PBS to remove any unbound lec-SOD or thine/xanthine oxidase (X/XO). Background levels of CLA chemilumi-
nescence in the presence of Marshall’s solution alone, 30 U/mL rhSODrhSOD, cells were detached (discussed previously in this
or lec-SOD were evaluated for two minutes prior to the addition ofarticle) and stained with an anti-human CuZn-SOD xanthine/xanthine oxidase (X/XO). Chemiluminescence resulting from
monoclonal antibody (mAb; SD-6; Sigma) and detected X/XO generated superoxide reaction with CLA was assessed for a
further five minutes. The addition of 30 U/mL of rhSOD or lec-SODwith a FITC-conjugated goat anti-mouse Ig. All incuba-
before and after 48-hour cold storage completely abrogated the superox-tions were performed on ice in the dark. Cells were ide-induced chemiluminescent signal on both occasions the experiments
washed twice with PBS and fixed with 1% formalin be- were performed.
fore data acquisition on a FACSort flow cytometer (Bec-
ton-Dickinson, Immunocytometry System, CA, USA)
and analysis using CellQuest software.
orescence and nonspecific binding of the secondary iso-Confocal laser microscopy analysis for localization of
type-specific, fluorescence-labeled antibody. Incubationbound lec-SOD. A total of 1  105 endothelial cells
of fibronectin-coated coverslips with lec-SOD showedin 200 L of supplemented medium were spread onto
there was no binding to fibronectin, and incubation ofcoverslips pre-treated with 50g/mL fibronectin solution
cells with lec-SOD followed by staining with an isotype(Boehringer Mannheim, Lewes, UK) and left overnight
control mAb showed no lec-SOD autofluorescence (datain a humidified 37C incubator. Once cells had firmly
not shown).adhered, they were cultured until confluent monolayers
Hypoxia/reoxygenation of endothelial cells. Confluentwere obtained (5 to 6 days).
endothelial cultures were placed inside a sealed perspexAnalysis to test for the internalization of lec-SOD
chamber and hypoxic conditions created by perfusion ofwas performed using the Leucoperm kit (Serotec Ltd.,
the chamber with 95% nitrogen, 5% CO2 until 0% oxy-Oxford, UK) according to the manufacturer’s protocol.
gen was detected by a Class T-7 Teledyne oxygen sensorBriefly, confluent endothelial monolayers were incu-
(Viamed, Keighley, UK) analyzed with a TED 60T oxy-bated with 50g/mL lec-SOD for three hours. Cells were
gen meter (Viamed). Following the period of hypoxia,permeabilized in the presence of an anti-human CuZn-
cells were washed once with PBS to remove unboundSOD mAb (IgG1; SD-6; Sigma), and lec-SOD was de-
lec-SOD and rhSOD, and fresh supplemented mediumtected with a FITC-conjugated secondary goat anti-
added and reoxygenation performed at 37C in a humidi-mouse IgG1 (Sigma) following incubation for 30 minutes
fied 5% CO2 incubator to simulate reperfusion condi-in the dark. The cells were washed twice with PBS, fixed
tions. This partially simulates the in vivo conditions inwith 1% formalin, mounted with Vectashield to pre-
which unbound SOD would be removed from the vascu-serve fluorescence (Vector Labs, Peterborough, UK) and
lature of the organ at reperfusion.stored at 4C in the dark. Cellular staining was analyzed
Effect of cold hypoxia on endothelial cell viability.on a Zeiss LSM410 confocal laser microscope. Low levels
Confluent cultures of endothelial cells in six-well platesof native SOD were detected in untreated cells following
were incubated under cold hypoxic conditions (95% N2,staining with an anti-SOD mAb. An irrelevant isotype
control antibody was used to check for cellular autoflu- 5% CO2) for 18, 24, and 27 hours in the presence of 1 mL
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Fig. 2. Lec-SOD binds with higher affinity to
HUVEC than rhSOD following incorporation
into Marshall’s cold preservation solution.
HUVEC were incubated with 25, 50, and 100
g/mL rhSOD at 4C for (A) 3 and (B) 24
hours. Exposure of cells to 50 g/mL lec-SOD
was analyzed for comparison. SOD binding
was determined by FACS with an anti-SOD
mAb detected with a FITC-conjugated goat
anti-mouse Ig. Lec-SOD bound with higher
affinity to endothelial cells than rhSOD under
organ preservation conditions. This experi-
ment was performed in triplicate with similar
results obtained on each occasion.
of lec-SOD, rhSOD, lecithin, or lecithin and unconju- Purified neutrophils were labeled with 50 Ci of so-
dium chromate (51Cr; Amersham International PLC,gated rhSOD in Marshall’s solution. Following cold hyp-
oxia, 2 mL of supplemented medium were added to each Bucks, UK) at 37C for one hour and were washed and
resuspended to a concentration of 1  107 cells/mL.well for reoxygenation at 37C in a humidified 5% CO2
incubator for 24 hours. Following reoxygenation, the Neutrophil-endothelial cell adhesion assay. Analysis
of neutrophil-endothelial cell adhesion (NECA) follow-remaining adherent cells were carefully detached, and
cell viability was determined by Trypan Blue exclusion ing cold hypoxia was not possible due to endothelial cell
contraction and consequent disruption of a continuousstaining. The experiment was performed in duplicate on
three separate occasions. monolayer. Therefore, a method adapted from Ichikawa
et al was performed [10]. Briefly, 1  104 endothelialPurification and labeling of neutrophils. Fifty milli-
liters of fresh peripheral blood were obtained from healthy cells were seeded onto 96-well plates (Greiner, UK) pre-
coated with 50 g/mL fibronectin solution (Boehringervolunteers and anticoagulated with 15% EDTA in 4.5
mL Vacutainer tubes (Becton Dickinson). Neutrophils Mannheim, Lewes, UK). Upon confluence, endothelial
cells were exposed to one-hour of hypoxia (95% N2, 5%were purified using a lipopolysaccharide-free method as
previously described [28]. More than 99% viability of CO2) and four hours of reoxygenation at 37C, and then
incubated with 5  105 neutrophils in a volume of 50 Lneutrophils was observed following Trypan Blue exclu-
sion staining, and neutrophil purity of 95% was ob- for 30 minutes at 37C after the period of reoxygenation.
Nonadherent neutrophils were removed by three re-tained as determined by morphological analysis follow-
ing Rapid Romanowski staining (HD Supplies, UK). peated washes and transferred onto a Spot-On filtermat
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(Wallac, Milton Keynes, UK), and adherent neutrophils
and endothelial cells were lysed with 50 L 0.1 mol/L
sodium hydroxide before transfer to filtermats. Gamma
emission was quantified on a Wallac 1205 Betaplate
Counter (Wallac), and the percentage of neutrophil ad-
herence was calculated. Each experiment was performed
at least three times, with ten samples per experiment.
Adhesion molecule expression following hypoxia/reoxy-
genation. To determine the adhesion molecules involved
in the NECA assay following one hour of hypoxia and
four-hours of reoxygenation of HUVEC and HMEC-1,
the endothelial cells were stained with antibodies against
CD31 (BBA7; British Biotech Ltd., Oxford, UK), P-selec-
tin (G1; [29]), E-selectin (5D11; British Biotech Ltd.)
and ICAM-1 (14C11; British Biotech Ltd.), and analyzed
by flow cytometry following detection with a fluorescein
isothiocyanate-conjugated goat anti-mouse Ig. The cells
were fixed in 1% formalin and analyzed by flow cytome-
try. An irrelevant isotype control antibody (anti-dog Thy-1
[30]) was used as a negative control. Mean fluorescence
index was calculated from the percentage of positive
cells gated relative to the mean channel fluorescence and
analyses were repeated on at least five occasions.
Statistical analyses
Statistical analyses using the Mann-Whitney U test
were performed to determine whether there were sig-
nificant differences between untreated and stimulated
endothelial cells at a significance level of P  0.05.
RESULTS
Lec-SOD and rhSOD maintain pharmacological
activity following storage in Marshall’s
preservation solution
The pharmacological efficacy of lecithinized superox-
ide dismutase (lec-SOD) following incorporation into
Marshall’s organ preservation solution was assessed by
a chemiluminescent technique involving the reaction of
xanthine/xanthine oxidase (X/XO) with a chemilumines- Fig. 3. Serial planar confocal laser microscopy images of lec-SOD bind-
ing to endothelial cell surface. HUVEC grown on collagen-coated glasscent probe, CLA..
coverslips were incubated with 50 g/mL of lec-SOD for three hours.
The addition of Marshall’s solution alone had no effect Cells were stained with an anti-SOD mAb following permeabilization
and staining detected with a FITC-conjugated goat anti-mouse Ig.on peak ·O2 production by X/XO over the five-minute
(A–H) Serial laser confocal 3.0 m sections through a single endothelialassay period (Fig. 1). In marked contrast, ·O2-induced cell, demonstrating lec-SOD present on the cell membrane with no
chemiluminescence was completely abrogated in the detectable SOD inside the cell. This photomicrography series is repre-
sentative of endothelial cells incubated with lec-SOD for three hourspresence of 30 U/mL of either rhSOD or lec-SOD. Fur-
and was performed on at least two separate occasions.thermore, the capacity of lec-SOD or rhSOD to scavenge
·O2 was not affected following 48 hours of cold storage
Lec-SOD but not rhSOD binds to endothelial cells inin Marshall’s preservation solution prior to the assay
cold Marshall’s preservation solution(Fig. 1). The results demonstrated that incorporation of
either rhSOD or lec-SOD into Marshall’s preservation During the period of organ preservation, an organ
solution did not affect their pharmacological potency, may be stored on ice for over 24 hours before trans-
plantation. To recreate similar physiological conditions,even after 48 hours of storage.
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Fig. 4. Analysis of endothelial lec-SOD bind-
ing following 24 hours of cold hypoxia and
prolonged reoxygenation. HUVEC were incu-
bated with lec-SOD for 24 hours of cold hyp-
oxia then reoxygenated for four hours, one
day, and three days to determine the period in
which lec-SOD remains bound to the surface.
Cells were stained with an anti-SOD mAb and
developed with a secondary goat anti-mouse
Ig for FACS analysis. The results demonstrated
a time-dependent decrease in surface levels
of lec-SOD proportional to the period of re-
oxygenation. This experiment was repeated
on three separate occasions, giving similar re-
sults.
endothelial cells were incubated at 4C for 3 and 24 hours bated with lec-SOD under cold hypoxic conditions for
24 hours, maximal levels of lec-SOD were detected afterwith 25, 50, and 100 g/mL of rhSOD or 50 g/mL lec-
SOD diluted in Marshall’s preservation solution. These four hours of warm reoxygenation, declining in a time-
dependent fashion after one and three days of reoxygen-concentrations of lec-SOD were selected based on stud-
ies performed by Igarashi et al, who demonstrated that ation, by which time levels were similar to native SOD
levels produced by HUVEC (Fig. 4). Similar results were100 g/mL lec-SOD bound with high affinity to endothe-
lial cells after incubation at 37C for three hours [20]. obtained for binding of lec-SOD to HMEC-1 following
hypoxia/ reoxygenation.Incubation of endothelial cells with rhSOD demon-
strated no binding above the basal levels of native SOD
Prolonged cold hypoxia and reoxygenation-inducedproduced by endothelial cells, whereas high levels were
endothelial cell death is partially inhibited by lec-SODdetected by flow cytometry following incubation with 50
g/mL lec-SOD (Fig. 2). The binding of lec-SOD to the No significant reduction in cell viability of HUVEC
was detected following 24 hours of cold hypoxia andsurface of endothelial cells was not affected by shear
forces created during removal of endothelial monolayers reoxygenation for 24 hours (78  3%) compared with
normoxic controls (84  3%; Fig. 5A), but a significantto form single cell suspensions and the repeated washing
steps during antibody staining protocols for flow cytome- reduction in cell viability was observed following 27
hours of cold hypoxia/reoxygenation (24  4%, P tric analysis. Subsequent titrations of lec-SOD demon-
strated that binding to HUVEC and HMEC-1 was detect- 0.01). However, incubation with 50 g/mL lec-SOD af-
forded a significant improvement in cell viability follow-able at similar levels throughout a range of concentrations
(for example, 10 to 100 g/mL lec-SOD) following 24- ing 27 hours of cold hypoxia (50  7%) compared with
HUVEC treated with 50 g/mL lecithin (21 3%) andhour cold storage (data not shown).
Laser confocal microscopy revealed that following cell 50 g/mL lecithin together with rhSOD unconjugated
(20 2%, all P 0.01). Similar levels of endothelial cellpermeabilization, lec-SOD was detectable only on the
surface of endothelial cells and no intracellular SOD was viability were observed after 30 hours of cold hypoxia/
reoxygenation.observed in 3.0 m serial planar laser images captured
through the endothelial cells (Fig. 3) Incubation of HMEC-1 cells for 18 and 24 hours of cold
hypoxia and reoxygenation did not result in a significant
Effect of hypoxia/reoxygenation on lec-SOD binding reduction in cell viability compared with normoxic endo-
to endothelial cells thelium (82  7% cells viable). In marked contrast, fol-
lowing 27 hours of cold hypoxia, a significant reductionHuman umbilical vein endothelial cells were incu-
bated for 24 hours in conditions of cold hypoxia (95% in cell viability was detected in HMEC-1 cells (27  7%),
and this remained significant regardless of treatmentN2, 5% CO2) in the presence of 50 g/mL lec-SOD and
reoxygenated at 37C for four hours, one day, and three (P 0.01). However, in HMEC-1 treated with 50 g/mL
lec-SOD, the reduction in cell viability was less markeddays to determine whether hypoxia/reoxygenation af-
fected surface levels of lec-SOD. In endothelial cells incu- (53  7%) and significantly better than treatment with
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either 50 g/mL lecithin (25 6%) or 50 g/mL lecithin
and rhSOD (24  7%, P  0.01; Fig. 5B).
Inhibition of neutrophil adhesion to hypoxia/
reoxygenation stimulated endothelial cells
following incubation with lec-SOD
Exposure of HUVEC to hypoxia/reoxygenation re-
sulted in a more than twofold increase in NECA (5.6 
0.8% to 12.0  2.6%, P  0.01), which was not signifi-
cantly inhibited with 50 g/mL rhSOD (10.1  0.9%),
50 g/mL lecithin (8.4  1.6%), or 50 g/mL lecithin
and rhSOD (8.9  1.9%; Fig. 6A), but treatment with
50 g/mL lec-SOD significantly abrogated increased
NECA (6.3  1.4%, P  0.01; Fig. 6A).
The HMEC-1 cells exposed to hypoxia/reoxygenation
exhibited a similar increase in neutrophil adhesion (5.6 
1.6% to 12.8  2.7%, P  0.01), which was significantly
reduced by treatment of HMEC-1 cells with 50 g/mL
lec-SOD (6.2  1.7%, P  0.01) but not with 50 g/mL
rhSOD (10.7  3.3%), 50 g/mL lecithin (10.4  3.7%),
or 50 g/mL of unconjugated lecithin and rhSOD (10.6
3.2%; Fig. 6B).
E-selectin and ICAM-1 are involved in NECA
following hypoxia/reoxygenation
Fluorescence-activated cell sorter (FACS) analysis was
performed to determine endothelial adhesion molecules
involved in the increased neutrophil adherence to hyp-
oxia/reoxygenation conditioned endothelial monolayers.
CD31 and ICAM-1 were constitutively expressed on
HUVEC, whereas P-selectin and E-selectin were absent
(Fig. 7A). Up-regulated expression of ICAM-1 was de-
tected on HUVEC exposed to hypoxia/reoxygenation
that was inhibited by 50 g/mL lec-SOD. E-selectin ex-
pression was also induced on HUVEC following hypoxia/
reoxygenation, but was only partially inhibited by 50g/mL
lec-SOD. The induction of P-selectin was not observed.
Constitutive expression of CD31 and ICAM-1 were
Fig. 5. Viability of HMEC-1 and HUVEC following cold hypoxia anddetected on unstimulated HMEC-1, with no expression reoxygenation for 24 hours. (A) HUVEC and (B) HMEC-1 cells were
of P-selectin or E-selectin (Fig. 7B). Following hypoxia/ incubated for 18, 24, and 27 hours under cold hypoxic conditions with
no () or 50 g/mL of lec-SOD (), lecithin ( ), or lecithin and rhSODreoxygenation, a marginal but consistent increase in both
( ), and then reoxygenated under normoxic conditions for 24 hours.ICAM-1 and E-selectin expression was detected on Cell viability was assessed by Trypan Blue exclusion staining after reoxy-
HMEC-1 that was inhibited by 50 g/mL lec-SOD. In- genation. Incubation of endothelial cells with 50 g/mL lec-SOD had
a significantly protective effect against 27 hours of cold hypoxia and 24duction of P-selectin was not observed on hypoxia/reoxy-
hours of warm reoxygenation compared with other treatments. Eachgenation-conditioned HMEC-1. value represents mean  SD for three experiments performed in dupli-
cate.
DISCUSSION
The aim of this study was to simulate the events that
may be directly targeted to the endothelium during theoccur during ischemia/reperfusion injury in renal trans-
period of cold storage and exert its protective effect onplantation using an in vitro endothelial cell model to
reperfusion.examine whether lec-SOD would be beneficial in pre-
We have determined that lec-SOD can be incorpo-venting oxygen free radical-derived damage. It was our
rated effectively in organ preservation solution, and canhypothesis that following flushing through the vascula-
ture of the organ with preservation solution, lec-SOD be detected bound to endothelial cells after 24 hours of
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Fig. 6. Comparison of effects of lec-SOD,
rhSOD, and lecithin on neutrophil adhesion
to HMEC-1 and HUVEC following one hour
of hypoxia and four hours of reoxygenation.
Confluent monolayers of (A) HUVEC and (B)
HMEC-1 were incubated for one hour under
hypoxic conditions either untreated or with
50 g/mL of lec-SOD, rhSOD, lecithin alone
or lecithin and rhSOD, together but unconju-
gated, and then reoxygenated for four hours.
51Cr-labeled neutrophils were incubated with
HUVEC and HMEC-1 after this period for
30 minutes before determining percentage
neutrophil adherence. Treatment of endothe-
lial cells with lec-SOD significantly inhibited
neutrophil adhesion to both HUVEC and
HMEC-1 stimulated by hypoxia/reoxygena-
tion (H/R). Each value represents mean  SD
for 10 measurements, replicated in three ex-
periments. *P  0.01 vs. normoxia; §P  0.01
vs. H/R HUVEC untreated.
cold hypoxic storage. In contrast, rhSOD did not bind to the initial period following transplantation of cadaver
renal allografts, but a delayed increase in CuZn-SODendothelial cells during the 24-hour cold hypoxic period.
Once the preservation solution containing rhSOD was production, peaking at day 2 post-transplant, was de-
tected by daily fine-needle aspirate biopsy analysis [31].removed, washed, and replaced with fresh medium, no
protective effects after reoxygenation were observed. This These results suggest that grafts would be unable to
respond to ·O2-mediated damage in the critical periodpartially simulates in vivo conditions where unbound
SOD would be removed from the vasculature of the immediately following reperfusion. Our results suggest
that storage of organs with lec-SOD may provide protec-organ at reperfusion. Lec-SOD was not detectable intra-
cellularly, as demonstrated by confocal laser microscopy tion in the initial phase of reperfusion injury when the
levels of native SOD within the graft are low. Despiteand planar laser imaging. However, intracellular uptake
of lec-SOD may not be critical, as increased surface the decline in lec-SOD after three days of reoxygenation
in our in vitro model, native levels of SOD produced inlevels may be more effective in reducing the insults from
ischemia/reperfusion. Exogenous SOD administered im- a graft may increase sufficiently to provide protection
from further damage.mediately prior to reperfusion has been shown to reduce
significantly the impact of oxygen free radical-derived Two clinical trials have been performed with superoxide
dismutase in renal transplantation. Pollak et al adminis-damage at the endothelial surface in renal transplanta-
tion [16, 17, 19]. tered SOD intravenously before and one-hour post-reper-
fusion, but no beneficial effects were observed with re-Furthermore, after hypoxia and warm reoxygenation,
lec-SOD remained on the cell surface and was detectable spect to early graft function [18]. In a separate trial, Land
et al administered a single, higher dose of SOD intrave-at maximal levels four hours after reoxygenation, declin-
ing in a time-dependent manner after three days. Native nously immediately prior to reperfusion. The results dem-
onstrated a significant reduction in first acute rejectionlevels of CuZn-SOD have been shown to be minimal in
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To determine whether lec-SOD had a protective role
in hypoxia-induced endothelial cell death, endothelial
cells were exposed to 18, 24, and 27 hours of cold hypoxia
in Marshall’s solution and reoxygenated for 24 hours
before assessment of cell viability. Our results demon-
strated that following 27 hours of cold hypoxia and reoxy-
genation, a significant reduction in endothelial viability
with increased cell detachment was observed, which was
prevented by incubation with 50 g/mL lec-SOD but not
the addition of rhSOD, lecithin, or lecithin and rhSOD
in combination. The protective effects of lec-SOD, but
not rhSOD or lecithin, suggest that lec-SOD may be effec-
tive in preventing cold hypoxia/reoxygenation-induced
cell death as a result of oxygen free radical production.
The effects of ischemia/reperfusion injury have been
simulated in many in vitro studies by exposing endothe-
lial cells to various periods of hypoxia/reoxygenation.
However, direct evidence for the role of oxygen free radi-
cals was provided from electron paramagnetic resonance
spectroscopy studies that demonstrated that in human
aortic endothelial cells subjected to a period of hypoxia
and reoxygenation, superoxide and hydroxyl radicals
were detected [4, 5]. These studies demonstrated that
the enzyme xanthine oxidase was the primary source of
free radical production.
An in vitro model of hypoxia/reoxygenation was
adapted from the study of Ichikawa et al to determine the
potential efficacy of lec-SOD in preventing neutrophil-
mediated damage. Incubation of endothelium with 50
g/mL lec-SOD during the one-hour hypoxic period sig-
nificantly attenuated neutrophil-endothelial cell adhesion
(NECA) to similar levels obtained for normoxic endo-
thelium, whereas treatment with lecithin alone, rhSOD
Fig. 7. Phenotypic analysis of HUVEC and HMEC-1 following hyp- or lecithin and rhSOD unconjugated did not reduceoxia/reoxygenation. Confluent monolayers of (A) HUVEC and (B)
NECA. Following hypoxia/reoxygenation, up-regulatedHMEC-1 were incubated for one hour of hypoxia and four hours of
reoxygenation either untreated or in the presence of 50 g/mL lec- expression of E-selectin and ICAM-1 were detected by
SOD. Endothelial cells were stained with mAb against CD31, P-selectin, FACS analysis, whereas expression of CD31 and P-selec-E-selectin and ICAM-1 and surface antigen expression detected with
tin was unchanged. Incubation of HUVEC with 50 g/mLa secondary FITC-conjugated goat anti-mouse Ig for FACS analysis.
The mean fluorescence index was determined from the mean fluores- lec-SOD prevented ICAM-1 up-regulation and partially
cence intensity and percentage of positive gated cells. Incubation of inhibited E-selectin induction. It is likely that inhibitionendothelial cells with lec-SOD appeared to significantly inhibit up-
of neutrophil adhesion by preservation with lec-SODregulation of ICAM-1 and E-selectin following hypoxia/reoxygenation.
These observations were representative of at least five separate experi- results from the inhibited up-regulation of ICAM-1 and
ments performed in duplicate. Symbols are: () unstimulated; ( ) E-selectin expression on hypoxia/reoxygenation-stimu-hypoxia/reoxygenation; () lec-SOD.
lated endothelium. These results support previous stud-
ies that demonstrated the participation of ICAM-1 and
E-selectin in NECA to hypoxia stimulated endothelial
episodes and improved one- and four-year graft survival cells using blocking antibody treatment [10, 36].
compared with placebo controls [19]. Although the in- Following hypoxic treatment of endothelial cells, in-
flammatory events associated with ischemia/reperfusion creased expression of adhesion molecules such as ICAM-1
injury may take place within a short time frame, there is and E-selectin may be up-regulated by oxygen-free radi-
accumulating evidence to suggest that these initial events cals via activation of nuclear factor-	B (NF-	B)–mediated
contribute to chronic allograft dysfunction. Many studies transcription [37]. In addition to hypoxic stimulation, in
have demonstrated that delayed graft function (DGF) vitro studies have been performed on endothelial cells
resulting from prolonged cold ischemia may significantly exposed to exogenous oxygen free radicals (for example,
hydrogen peroxide, X/XO), which have resulted in ele-diminish long-term renal allograft survival [32–35].
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vascular endothelial cell-1; H2O2, hydrogen peroxide; HTK, histidine,vated expression of ICAM-1 and P-selectin and in-
tryptophan, -ketoglutarate; HUVEC, human umbilical vein endothe-
creased binding of neutrophils [38–41]. P-selectin expres- lial; ICAM-1, intercellular adhesion molecule-1; IRI, ischemia/reperfu-
sion has been demonstrated in hypoxia/reoxygenation sion injury; lec-SOD, lecithinized superoxide dismutase; NECA, neutro-
phil endothelial cell adhesion; ·O2, superoxide; OH hydroxyl radical;of endothelial cells [9, 10, 42, 43], but in the current
rhSOD, recombinant human CuZn superoxide dismutase; PBS, phos-study, P-selectin expression was not detected in HUVEC phate-buffered saline; TNF, tumor necrosis factor; UW, University of
four-hours post-reoxygenation nor at the earlier time Wisconsin; X/XO, xanthanine/xanthine oxidase.
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